Skip to main content
Clinical Trials/NCT05476809
NCT05476809
Completed
Not Applicable

A Clinical Trial on an Upgraded Smart Cloth Home Care System With Interactive Family Caregiver App for Persons With Dementia

Chang Gung Memorial Hospital2 sites in 1 country60 target enrollmentNovember 1, 2022
ConditionsDementiaFamily

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Dementia
Sponsor
Chang Gung Memorial Hospital
Enrollment
60
Locations
2
Primary Endpoint
Caregiving Balance
Status
Completed
Last Updated
5 months ago

Overview

Brief Summary

The purposes of this study are to develop an upgraded version of the smart-clothes home care model that include an interactive family caregiver App, and to examine its effect on a randomized controlled trial.

Detailed Description

The purposes of this study are to develop an upgraded version of the smart-clothes home care model that include an interactive family caregiver App, and to examine its effect on a randomized controlled trial. This 3-year study will spend the first 6 months to developed the upgraded smart-clothes home care model, and the later 2 and a half years on the clinical trial and follow-ups. In addition to the original function of abnormal activity level, going out alone, abnormal number of getting-up at night, fall risks, this upgraded version will include monitoring for medication, abnormal life pattern, quality of hired help. The warning signals, along with weekly summary and related information will be sent to the family caregiver interactive App after the assessment of the home care nurses to provide guidance for family care. During the first 6 months, the upgraded smart-clothes home care model will be developed according to qualitative and quantitative data of the prior study and expert reviews. For the clinical trial in later 2 1/2 years, a total of 60 participant families will be randomly assigned to experimental (N=30) and control (N=30) group, with experimental group receiving the upgraded smart-clothes home care for 6 months and control group received routine care with 6 month follow-ups. Outcomes including caregiver preparedness, balance between competing needs, health related quality of life and depressive symptoms, and fall, time up \& go, activities of daily living (ADLs), instrumental ADLs, cognitive function and quality of life of the patient will be followed every 2 month for 6 months. Intention-to-treat and hierarchical linear models will be used to analyze the results.

Registry
clinicaltrials.gov
Start Date
November 1, 2022
End Date
December 31, 2024
Last Updated
5 months ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Chang Gung Memorial Hospital
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Diagnosed as having dementia
  • can walk independently or with help
  • able to communicate
  • living in Northern Taiwan.
  • Family caregiver age 20 or older
  • taking primary responsibility in providing family care.

Exclusion Criteria

  • with terminal illness
  • with severe diseases that can not be controlled.

Outcomes

Primary Outcomes

Caregiving Balance

Time Frame: 6 month after Baseline

The degree of balance between competing needs will be measured by the Caregiving Process of Finding a Balance Point measure (Shyu, 2002).

caregiver preparedness

Time Frame: 6 months after baseline

Preparedness is measured by self-report with an 8-item scale. This scale asks caregivers to rate how well-prepared they think they are for seven domains of caregiving.

caregiver depressive symptoms

Time Frame: 6 months after baseline

Centre for Epidemiologic Studies Depression Scale (CES-D)

Caregiving Health Related Quality of Life

Time Frame: 6 month after Baseline

Medical Outcome SF-36 Taiwan version

Secondary Outcomes

  • Activities of Daily Living (ADL)(6 months after baseline)
  • Time Up and Go test(6 month after baseline)
  • Cognitive function(6 month after baseline)
  • Instrumental activities of daily living (IADL)(6 months after baseline)
  • Health related quality of life for PLWD(6 month after baseline)

Study Sites (2)

Loading locations...

Similar Trials